Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Sundell

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 26, 2018
Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometryJesper Sundell, Emile Bienvenu, Sofia Birgersson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT intervalJesper Sundell, Dinko Rekic, Johanna Melin, et al.
Pharmacology Research & Perspectives|March 6, 2024
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic dosesJoanna Parkinson, Jesper Sundell, Dinko Rekić, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 26, 2018
Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometryJesper Sundell, Emile Bienvenu, Sofia Birgersson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT intervalJesper Sundell, Dinko Rekic, Johanna Melin, et al.
Pharmacology Research & Perspectives|March 6, 2024
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic dosesJoanna Parkinson, Jesper Sundell, Dinko Rekić, et al.
Pageof 2